Transforming medical practice: from treatment to cure
Over the past few decades, conventional pharmacological treatments have allowed clinicians to cure or control numerous acute and chronic diseases. Despite this success, there are many diseases for which there are no cures. Regenerative medicine and cell therapy are the most promising health research developments that have occurred in recent yea
rs. These allow for the removal and replacement of diseased cells, the correction of genetic defects and the rebuilding of lost or damaged cells. The untapped potential of stem cell research offers tremendous hope for diseases for which there is currently no effective therapy. Moreover, it can provide substantial reductions in both the direct and indirect health care costs of treating chronic diseases. Every day, groundbreaking discoveries make their way to clinical trials, bringing innovative cell therapy treatments closer to patients with cancer, diabetes, cardiovascular diseases, ocular diseases, neurological disorders, blood disorders and other health issues. CellCAN will propel regenerative medicine and cell therapy research forward by creating an unprecedented bridge between all stakeholders in stem cell research: researchers, clinicians, funders, industry, charities, government members, patient representatives and the public.
